Five-year optical coherence tomography follow-up of an everolimus-eluting bioresorbable vascular scaffold: changing the paradigm of coronary stenting?
Department of Interventional Cardiology, Thoraxcentre, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Antonios
A
Karanasos
Cihan
C
Simsek
Patrick
P
Serruys
Jurgen
J
Ligthart
Karen
K
Witberg
Robert-Jan
RJ
van Geuns
George
G
Sianos
Felix
F
Zijlstra
Evelyn
E
Regar
D060050:Angina, Stable / Q000175:diagnosis* / Q000188:drug therapy*; D001672:Biocompatible Materials; D003324:Coronary Artery Disease / Q000175:diagnosis* / Q000188:drug therapy*; D054855:Drug-Eluting Stents; D000068338:Everolimus; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D020123:Sirolimus / Q000008:administration & dosage / Q000031:analogs & derivatives*; D041623:Tomography, Optical Coherence
D001672:Biocompatible Materials; D007166:Immunosuppressive Agents; D000068338:Everolimus; D020123:Sirolimus